We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

HUMAN GMBH

HUMAN offers a broad portfolio of in vitro diagnostic products with more than 400 products in 12 areas covering the w... read more Featured Products: More products

Download Mobile App





HUMAN Diagnostics Showcases Innovative FIA and Hematology Solutions

By LabMedica International staff writers
Posted on 24 Jul 2023

HUMAN Diagnostics (Wiesbaden, Germany), a leading global provider of in-vitro diagnostic solutions, is participating in the 2023 AACC Clinical Lab Expo taking place from July 25th to 27th in Anaheim, CA, USA. More...

As a prominent exhibitor, HUMAN is located at Booth #921, where the company is showcasing its cutting-edge products and engaging with industry professionals, researchers, and healthcare experts. The company's presence at the expo reaffirms its commitment to delivering high-quality diagnostic solutions that contribute to advancing patient care and laboratory excellence.

Among the products being featured at the exhibition is the HumaCount 5D CRP, an innovative hematology analyzer that provides rapid and precise measurement of C-reactive protein (CRP), a crucial biomarker for inflammation assessment. With its advanced technology and user-friendly interface, HumaCount 5D CRP delivers reliable results and enhances laboratory efficiency. Also being highlighted at the show is the HumaNex A1c Variant which offers a breakthrough in glycated hemoglobin (A1c) testing. This fully automated assay delivers accurate results for A1c testing, even in the presence of hemoglobin variants, ensuring reliable diabetes management and monitoring.

The company is also highlighting the HumaFIA system, a high-performance fluorescence immunoassay analyzer designed for rapid and sensitive measurement of various analytes. With its versatility and efficiency, HumaFIA facilitates precise diagnostics across a wide range of applications. At the event, HUMAN's team of experts is available to discuss the company's comprehensive product portfolio, provide demonstrations, and answer any questions from attendees.

"We are excited to participate in the prestigious AACC Clinical Lab Expo and present our latest advancements in diagnostic solutions," said Thomas Roesser, Vice President International Sales. "At HUMAN, we are dedicated to developing innovative products that empower healthcare professionals to make informed decisions and improve patient outcomes."

Related Links:
HUMAN Diagnostics 


New
Gold Member
Collection and Transport System
PurSafe Plus®
Portable Electronic Pipette
Mini 96
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.